MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/hep.32163

Медицинская библиотека · Hepatology (Baltimore, Md.) · 2021

Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases.

Ginès Pere, Castera Laurent, Lammert Frank, Graupera Isabel, Serra-Burriel Miquel, Allen Alina M, Wong Vincent Wai-Sun, Hartmann Phillipp, Thiele Maja, Caballeria Llorenç, de Knegt Robert J, Grgurevic Ivica, Augustin Salvador, Tsochatzis Emmanuel A, Schattenberg Jörn M, Guha Indra Neil, Martini Andrea, Morillas Rosa M, Garcia-Retortillo Montserrat, de Koning Harry J, Fabrellas Núria, Pich Judit, Ma Ann T, Diaz M Alba, Roulot Dominique, Newsome Philip N, Manns Michael, Kamath Patrick S, Krag Aleksander, LiverScreen Consortium Investigators

СтатьяПоддержка исследования: вне правительства СШАОбзорПеревод пока не подготовлен

Аннотация

Cirrhosis, highly prevalent worldwide, develops after years of hepatic inflammation triggering progressive fibrosis. Currently, the main etiologies of cirrhosis are non-alcoholic fatty liver disease and alcohol-related liver disease, although chronic hepatitis B and C infections are still major etiological factors in some areas of the world. Recent studies have shown that liver fibrosis can be assessed with relatively high accuracy noninvasively by serological tests, transient elastography, and radiological methods. These modalities may be utilized for screening for liver fibrosis in at-risk populations. Thus far, a limited number of population-based studies using noninvasive tests in different areas of the world indicate that a significant percentage of subjects without known liver disease (around 5% in general populations and a higher rate -18% to 27%-in populations with risk factors for liver disease) have significant undetected liver fibrosis or established cirrhosis. Larger international studies are required to show the harms and benefits before concluding that screening for liver fibrosis should be applied to populations at risk for chronic liver diseases. Screening for liver fibrosis has the potential for changing the current approach from diagnosing chronic liver diseases late when patients have already developed complications of cirrhosis to diagnosing liver fibrosis in asymptomatic subjects providing the opportunity of preventing disease progression.

Для цитирования: Ginès Pere, Castera Laurent, Lammert Frank, Graupera Isabel, Serra-Burriel Miquel, Allen Alina M, Wong Vincent Wai-Sun, Hartmann Phillipp, Thiele Maja, Caballeria Llorenç, de Knegt Robert J, Grgurevic Ivica, Augustin Salvador, Tsochatzis Emmanuel A, Schattenberg Jörn M, Guha Indra Neil, Martini Andrea, Morillas Rosa M, Garcia-Retortillo Montserrat, de Koning Harry J, Fabrellas Núria, Pich Judit, Ma Ann T, Diaz M Alba, Roulot Dominique, Newsome Philip N, Manns Michael, Kamath Patrick S, Krag Aleksander, LiverScreen Consortium Investigators. Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases.. Hepatology (Baltimore, Md.). 2021. DOI: 10.1002/hep.32163.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.